This study evaluated potential predictors of erosions and joint space narrowing (JSN) in patients with early rheumatoid arthritis (RA). The data showed that less JSN progression was seen in postmenopausal, overweight women with RA, and smoking was associated with JSN progression.

This study investigated the possible effects of Punica granatum (pomegranate) on indicators and symptoms caused by rheumatoid arthritis (RA).

The data showed that pomegranate may have a positive impact on RA-related indicators and symptoms.

This study evaluated the impact of different times after chemotherapy until breast cancer surgery on complications after surgery and survival outcomes. The data showed the optimal time to surgery (TTS) was between 21 and 28 days after chemotherapy in these patients. 

This article looked at the use of physical activity (PA) in improving sleep problems in breast cancer (BC) survivors. The authors found that PA may be effective in improving sleep quality in BC survivors. 

This study examined whether a healthy diet can improve the quality of life of women with breast cancer undergoing chemotherapy. The authors found that women who followed healthy dietary advice had an improvement in the quality of their life during chemotherapy, reducing nausea, vomiting, and increasing appetite. 

This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity.

This study looked at the use of modified radical mastectomy (MRM) in the treatment of newly diagnosed stage IV inflammatory breast cancer (IBC). The authors found that MRM is associated with improved survival in these patients.  

This study evaluated the impact of radiotherapy (RT) on controlling brain metastasis (BM). The study suggested that a single dose of RT was effective in controlling small BM. Larger BM could be controlled more effectively with multiple rounds of RT.

This study reviewed the effectiveness of baricitinib (Olumiant) on the progression of structural joint damage (SJD) in patients with rheumatoid arthritis (RA).

The data showed that baricitinib may significantly help slow down SJD signs found in digital imaging in patients with non-existent or insufficient response to standard treatment drugs.

This study examined the effect of sarilumab (Kevzara) compared to adalimumab (Humira) on health-related quality of life (HRQoL) based on inflammatory marker levels in patients with rheumatoid arthritis (RA). 

The data showed that sarilumab has a higher effect on improving aspects of HRQoL in patients with higher levels of inflammation in the blood.